These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 32829908)
21. Stroke risks and patterns of warfarin therapy among atrial fibrillation patients post radiofrequency ablation: A real-world experience. Zhang J; Liu X; Liu X; Yin X; Wang Y; Lu X; Yang X Medicine (Baltimore); 2017 Nov; 96(47):e8762. PubMed ID: 29381974 [TBL] [Abstract][Full Text] [Related]
22. Brain hemorrhage on 24h-CT and functional outcome in stroke patients with cerebral amyloid angiopathy features on pre-thrombolysis MRI treated with intravenous thrombolysis: A case series. Leonte A; Laurent-Chabalier S; Wacongne A; Parvu T; Hackius M; Thouvenot E; Renard D J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106907. PubMed ID: 36442282 [TBL] [Abstract][Full Text] [Related]
23. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study. Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386 [TBL] [Abstract][Full Text] [Related]
25. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK; BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652 [TBL] [Abstract][Full Text] [Related]
26. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [TBL] [Abstract][Full Text] [Related]
27. Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage. Stanton RJ; Eckman MH; Woo D; Moomaw CJ; Haverbusch M; Flaherty ML; Kleindorfer DO Stroke; 2020 Mar; 51(3):808-814. PubMed ID: 32000590 [TBL] [Abstract][Full Text] [Related]
28. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation. Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794 [TBL] [Abstract][Full Text] [Related]
29. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage. Chao TF; Liu CJ; Liao JN; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Lip GY; Chen SA Circulation; 2016 Apr; 133(16):1540-7. PubMed ID: 26969761 [TBL] [Abstract][Full Text] [Related]
31. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005 [TBL] [Abstract][Full Text] [Related]
32. Intracerebral Hemorrhage Recurrence in Patients with and without Cerebral Amyloid Angiopathy. Pinho J; Araújo JM; Costa AS; Silva F; Francisco A; Quintas-Neves M; Soares-Fernandes J; Ferreira C; Oliveira TG Cerebrovasc Dis Extra; 2021; 11(1):15-21. PubMed ID: 33503633 [TBL] [Abstract][Full Text] [Related]
33. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience. Barnes GD; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Froehlich JB; Kaatz S Thromb Res; 2014 Aug; 134(2):294-9. PubMed ID: 24929840 [TBL] [Abstract][Full Text] [Related]
34. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422 [TBL] [Abstract][Full Text] [Related]
35. Atrial fibrillation and medication treatment among centenarians: Are all very old patients treated the same? Kreutz R; Schmidt IM; Dräger D; Brüggen F; Hörter S; Zwillich C; Kuhlmey A; Gellert P Geriatr Gerontol Int; 2018 Dec; 18(12):1634-1640. PubMed ID: 30259631 [TBL] [Abstract][Full Text] [Related]
36. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation. Hilkens NA; Algra A; Greving JP Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618 [TBL] [Abstract][Full Text] [Related]
37. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143 [TBL] [Abstract][Full Text] [Related]
38. Stroke risk scores for prediction of mortality and hemorrhages in atrial fibrillation patients. Ivănescu AC; Delcea C; Dan GA Rom J Intern Med; 2022 Sep; 60(3):182-192. PubMed ID: 35687080 [No Abstract] [Full Text] [Related]
39. Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA Bel-Ange A; Itskovich SZ; Avivi L; Stav K; Efrati S; Beberashvili I BMC Nephrol; 2021 May; 22(1):179. PubMed ID: 33992086 [TBL] [Abstract][Full Text] [Related]